Antithrombin-binding oligosaccharides: structural diversities in a unique function? (Q38304819)

1 September 2017

Antithrombin-binding oligosaccharides: structural diversities in a unique function? (English)

1 reference

1 September 2017

1 reference

Marco Guerrini

1

0 references

author name string

Pierre A J Mourier

series ordinal

2

1 reference

1 September 2017

Giangiacomo Torri

series ordinal

3

1 reference

1 September 2017

Christian Viskov

series ordinal

4

1 reference

1 September 2017

1 October 2014

1 reference

1 September 2017

Glycoconjugate Journal

1 reference

1 September 2017

31

1 reference

1 September 2017

6-7

1 reference

1 September 2017

409-416

1 reference

https://scigraph.springernature.com/pub.10.1007/s10719-014-9543-9

1 September 2017

0 references

cites work

Low molecular weight heparins: structural differentiation by bidimensional nuclear magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1007%2FS10719-014-9543-9

Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-014-9543-9

Serpin structure, function and dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-014-9543-9

A unique trisaccharide sequence in heparin mediates the early step of antithrombin III activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-014-9543-9

The anticoagulant activation of antithrombin by heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-014-9543-9

Structure of beta-antithrombin and the effect of glycosylation on antithrombin's heparin affinity and activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-014-9543-9

A synthetic antithrombin III binding pentasaccharide is now a drug! What comes next?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-014-9543-9

Antithrombin-S195A factor Xa-heparin structure reveals the allosteric mechanism of antithrombin activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-014-9543-9

New antithrombin-based anticoagulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-014-9543-9

Structural variation in the antithrombin III binding site region and its occurrence in heparin from different sources

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-014-9543-9

Pharmacokinetic and pharmacodynamic properties of oral anticoagulants, especially phenprocoumon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-014-9543-9

Standardization of prothrombin time for laboratory control of oral anticoagulant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-014-9543-9

Chromatographic analysis and sequencing approach of heparin oligosaccharides using cetyltrimethylammonium dynamically coated stationary phases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-014-9543-9

Heparan sulfate 3-O-sulfation: a rare modification in search of a function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-014-9543-9

Chemoenzymatic synthesis of homogeneous ultralow molecular weight heparins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-014-9543-9

Chemoenzymatic synthesis of heparin oligosaccharides with both anti-factor Xa and anti-factor IIa activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-014-9543-9

Structure and activity of a new low-molecular-weight heparin produced by enzymatic ultrafiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-014-9543-9

Structure-function relations of antithrombin III-heparin interactions as assessed by biophysical and biological assays and molecular modeling of peptide-pentasaccharide-docked complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-014-9543-9

Enzymatic preparation of heparin oligosaccharides containing antithrombin III binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-014-9543-9

Using an enzymatic combinatorial approach to identify anticoagulant heparan sulfate structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-014-9543-9

Antithrombin-binding octasaccharides and role of extensions of the active pentasaccharide sequence in the specificity and strength of interaction. Evidence for very high affinity induced by an unusual glucuronic acid residue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-014-9543-9

Update of the recommendations on biosimilar low-molecular-weight heparins from the Scientific Subcommittee on Control of Anticoagulation of the International Society on Thrombosis and Haemostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-014-9543-9

Conformational changes in serpins: II. The mechanism of activation of antithrombin by heparin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-014-9543-9

Mechanism of heparin activation of antithrombin. Role of individual residues of the pentasaccharide activating sequence in the recognition of native and activated states of antithrombin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-014-9543-9

Active conformations of glycosaminoglycans. NMR determination of the conformation of heparin sequences complexed with antithrombin and fibroblast growth factors in solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-014-9543-9

Conformation of the pentasaccharide corresponding to the binding site of heparin to antithrombin-III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-014-9543-9

Conformational flexibility: a new concept for explaining binding and biological properties of iduronic acid-containing glycosaminoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-014-9543-9

Structural insights into biological roles of protein-glycosaminoglycan interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-014-9543-9

N.m.r. and molecular-modelling studies of the solution conformation of heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-014-9543-9

Structure of a heparin-linked biologically active dimer of fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-014-9543-9

Interaction of heparins with fibroblast growth factors: conformational aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-014-9543-9

Heparin modulates the mitogenic activity of fibroblast growth factor by inducing dimerization of its receptor. a 3D view by using NMR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-014-9543-9

Effects on molecular conformation and anticoagulant activities of 1,6-anhydrosugars at the reducing terminal of antithrombin-binding octasaccharides isolated from low-molecular-weight heparin enoxaparin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-014-9543-9

An unusual antithrombin-binding heparin octasaccharide with an additional 3-O-sulfated glucosamine in the active pentasaccharide sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-014-9543-9

Heparin dodecasaccharide containing two antithrombin-binding pentasaccharides: structural features and biological properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-014-9543-9

Characterization of heparin-protein interaction by saturation transfer difference (STD) NMR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-014-9543-9

Complete relaxation and conformational exchange matrix (CORCEMA) analysis of NOESY spectra of interacting systems; two-dimensional transferred NOESY.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-014-9543-9

The effect of a reducing-end extension on pentasaccharide binding by antithrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-014-9543-9

Isolation of a pure octadecasaccharide with antithrombin activity from an ultra-low-molecular-weight heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-014-9543-9

Dissecting the substrate recognition of 3-O-sulfotransferase for the biosynthesis of anticoagulant heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-014-9543-9

Conformation of heparin pentasaccharide bound to antithrombin III

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS10719-014-9543-9

21 January 2018

12 December 2020

Characterization of di- and monosulfated, unsaturated heparin disaccharides with terminal N-sulfated 1,6-anhydro-β-d-glucosamine or N-sulfated 1,6-anhydro-β-d-mannosamine residues

1 reference

https://api.crossref.org/works/10.1007%2FS10719-014-9543-9

Characterization of unfractionated heparin: comparison of materials from the last 50 years.

21 January 2018

1 reference

12 December 2020

Structural characterization of low molecular weight heparins

1 reference

12 December 2020

Structural studies on a biologically active hexasaccharide obtained from heparin

1 reference

12 December 2020

Differentiation of beef and pig mucosal heparins by NMR spectroscopy

1 reference

12 December 2020

Production and chemical processing of low molecular weight heparins.

1 reference

12 December 2020

Extension and structural variability of the antithrombin-binding sequence in heparin.

1 reference

12 December 2020

Structural features of low-molecular-weight heparins affecting their affinity to antithrombin.

1 reference

12 December 2020

Heparin and low-molecular-weight heparin

1 reference

12 December 2020

Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity

1 reference

12 December 2020

10.1007/S10719-014-9543-9

Identifiers

DOI

1 reference

Dimensions Publication ID

1 September 2017

0 references

1 reference